[{"NetIncomeLoss_1_Q3_USD":-11617000.0,"DepreciationAndAmortization_3_Q3_USD":3352000.0,"DepreciationAndAmortization_1_Q3_USD":1244000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":2184000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":8596000.0,"InterestPaidNet_3_Q3_USD":1942000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-3729000.0,"Depreciation_3_Q3_USD":1277000.0,"Depreciation_1_Q3_USD":462000.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":-2271000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":-763000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":2175000.0,"AssetsCurrent_0_Q3_USD":145660000.0,"OperatingLeaseExpense_3_Q3_USD":1160000.0,"OperatingLeaseExpense_1_Q3_USD":533000.0,"LongTermDebt_0_Q3_USD":32363000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":31970000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":13725000.0,"FinanceLeaseLiabilityNoncurrent_0_Q3_USD":262000.0,"DebtInstrumentUnamortizedDiscount_0_Q3_USD":439000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":5608329.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":30000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":2561000.0,"AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_3_Q3_USD":3219000.0,"CommonStockSharesIssued_0_Q3_shares":37177371.0,"Assets_0_Q3_USD":195411000.0,"ShareBasedCompensation_3_Q3_USD":2628000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":6955947.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0,"Liabilities_0_Q3_USD":58019000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":120150000.0,"OtherAssetsNoncurrent_0_Q3_USD":338000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-1003000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":10138000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":3999000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":12806000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":6336000.0,"EarningsPerShareBasic_3_Q3_USD":-1.15,"EarningsPerShareBasic_1_Q3_USD":-0.31,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":2121000.0,"FinanceLeasePrincipalPayments_3_Q3_USD":250000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":23407358.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":37162489.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":2206000.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":2476000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-244000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-126000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":2204000.0,"AccountsReceivableNetCurrent_0_Q3_USD":9605000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-11000.0,"NumberOfReportableSegments_3_Q3_segment":1.0,"DepreciationDepletionAndAmortization_3_Q3_USD":3418000.0,"ContractWithCustomerAssetNet_0_Q3_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":136886000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_3_Q3_USD":1590000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":1050000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q3_USD":224000.0,"TemporaryEquityAccretionToRedemptionValueAdjustment_3_Q3_USD":296000.0,"FairValueAdjustmentOfWarrants_3_Q3_USD":2728000.0,"OtherAssetsCurrent_0_Q3_USD":9812000.0,"IncreaseDecreaseInInventories_3_Q3_USD":2272000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-26993000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-11617000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-23000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":608000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":9017000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":38759000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":3541000.0,"Goodwill_0_Q3_USD":18262000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-25285000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-11628000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":1158000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-30214000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":23407358.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":37162489.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q3_USD":1210000.0,"CostOfRevenue_3_Q3_USD":14767000.0,"CostOfRevenue_1_Q3_USD":5023000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":2470000.0,"LiabilitiesCurrent_0_Q3_USD":17300000.0,"AccountsPayableCurrent_0_Q3_USD":4071000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":120451000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":173000.0,"LongTermDebtNoncurrent_0_Q3_USD":32363000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":2625000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":21374000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3_Q3_pure":0.21,"GrossProfit_3_Q3_USD":23992000.0,"GrossProfit_1_Q3_USD":8453000.0,"AdditionalPaidInCapital_0_Q3_USD":215824000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":21374000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":134000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":438000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q3_USD":6824000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":6492000.0,"NetIncomeLoss_3_Q3_USD":-25262000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":2184000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":2184000.0,"RestrictedCashNoncurrent_0_Q3_USD":301000.0,"EarningsPerShareDiluted_1_Q3_USD":-0.31,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":13476000.0,"OperatingIncomeLoss_3_Q3_USD":-22518000.0,"OperatingIncomeLoss_1_Q3_USD":-10739000.0,"InventoryNet_0_Q3_USD":6093000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":4354000.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":27710000.0,"TemporaryEquityAccretionOfDividends_3_Q3_USD":1435000.0,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":-36000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":195411000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":4157000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"AmortizationOfDebtDiscountPremium_3_Q3_USD":319000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":10033000.0,"CommonStockSharesAuthorized_0_Q3_shares":500000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":525000.0,"OperatingExpenses_1_Q3_USD":19192000.0,"ProfitLoss_3_Q3_USD":-25262000.0,"FinanceLeaseLiabilityCurrent_0_Q3_USD":279000.0,"StockholdersEquity_0_Q3_USD":137392000.0,"RedeemablePreferredStockDividends_3_Q3_USD":1435000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":1136000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":3729000.0,"DebtInstrumentCarryingAmount_0_Q3_USD":32500000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":78000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-78434000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":102943000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":3135000.0,"CommonStockSharesOutstanding_0_Q3_shares":37177371.0,"EarningsPerShareDiluted_3_Q3_USD":-1.15,"OperatingExpenses_3_Q3_USD":46510000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":638000.0,"Ticker":"AKYA","CIK":"1711933","name":"AKOYA BIOSCIENCES, INC.","OfficialName":"Akoya BioSciences Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"413727411.0","Country":"United States","Sector":"Capital Goods","Industry":"Medical Specialities","Market":"NASDAQ","SP500":"nan","filed":"20211109"}]